• AAPL 173.5
  • TSLA 194.05
  • AMZN 180.96
  • MSFT 402.25
  • INTC 31.36
  • EURUSD 1.0724
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. IL /
  3. 0RDV.IL

Grifols SA Pref (0RDV IL) stock market data APIs

€5.945 0.04(0.7%) as of April 29, 2024

Grifols SA Pref Financial Data Overview

5.9075
5.945
-
5.945
5.9
4.914-10.94
5 808 M
36.8566
256 M
6 479 M
0.5034
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '0RDV',
Type: 'Preferred Stock',
Name: 'Grifols SA Pref',
Exchange: 'IL',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'UK',
CountryISO: 'GB',
OpenFigi: NULL,
ISIN: 'ES0171996095',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

Grifols SA Pref Fundamental Data is available in our Financial Data APIs

  • Net Revenue 6 479 M
  • EBITDA 921 M
  • Earnings Per Share 0.16
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Grifols SA Pref Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Grifols SA Pref End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Grifols SA Pref latest news via APIs

Grifols 2023 Annual Report on Form 20-F filed with the SEC

BARCELONA, Spain, April 19, 2024 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, toda...

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

Grifols, S.A. The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three plasma industry leader and setting the stage for sustained business gro...
Do you have any questions?
support@eodhistoricaldata.com